Trinity Biotech Plc Stock Alpha and Beta Analysis
| TRIB Stock | USD 0.75 0.04 5.06% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Trinity Biotech plc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Trinity Biotech over a specified time horizon. Remember, high Trinity Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Trinity Biotech's market risk premium analysis include:
Beta 1.31 | Alpha (0.30) | Risk 8.04 | Sharpe Ratio (0.04) | Expected Return (0.33) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Trinity Biotech Backtesting, Trinity Biotech Valuation, Trinity Biotech Correlation, Trinity Biotech Hype Analysis, Trinity Biotech Volatility, Trinity Biotech History and analyze Trinity Biotech Performance. Trinity Biotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Trinity Biotech market risk premium is the additional return an investor will receive from holding Trinity Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Trinity Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Trinity Biotech's performance over market.| α | -0.3 | β | 1.31 |
Trinity Biotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Trinity Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Trinity Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Trinity Biotech Market Price Analysis
Market price analysis indicators help investors to evaluate how Trinity Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Trinity Biotech shares will generate the highest return on investment. By understating and applying Trinity Biotech stock market price indicators, traders can identify Trinity Biotech position entry and exit signals to maximize returns.
Trinity Biotech Return and Market Media
The median price of Trinity Biotech for the period between Sun, Oct 5, 2025 and Sat, Jan 3, 2026 is 1.0 with a coefficient of variation of 10.48. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 0.98, and mean deviation of 0.08. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Jacksonville beats Trinity 132-45 | 11/07/2025 |
2 | Americore Resources Corp. Closes Trinity Silver Project Agreement with Newmont | 11/18/2025 |
3 | CrownPoint Partners Brokers Sale-Leaseback of Trinity Dental Arts in Trinity, Florida | 12/01/2025 |
4 | Trinity Capital Expands Venture-Focused Financing | 12/08/2025 |
5 | Trinity Industries, Inc. TRN Shares Acquired by JPMorgan Chase Co. | 12/09/2025 |
6 | Trinity Habitat for Humanity builds affordable homes for working families in North Texas | 12/11/2025 |
7 | Trinity Hills Valley, S.A. Signs Franchise Agreement with Marriott International for Tribute Portfolio Hotel and Residences at Surf Lagoon-Anchored Resort in Pa... | 12/16/2025 |
8 | Trinity Investments Expands European Platform With Acquisition of The Hoxton, Poblenou in Barcelona | 12/18/2025 |
9 | Trinity Biotech Stock Jumps 60 percent After Major Breakthrough | 12/23/2025 |
10 | What Caused Multi Ways Holdings To Soar Nearly 49 percent In After-Hours Trading | 12/24/2025 |
11 | Callous day care owner allegedly killed infant by bashing his head into floor during diaper change | 12/31/2025 |
About Trinity Biotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Trinity or other stocks. Alpha measures the amount that position in Trinity Biotech plc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Dividend Yield | 0.00337 | 0.001908 | Price To Sales Ratio | 1.48 | 1.4 |
Trinity Biotech Upcoming Company Events
As portrayed in its financial statements, the presentation of Trinity Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Trinity Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Trinity Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Trinity Biotech. Please utilize our Beneish M Score to check the likelihood of Trinity Biotech's management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 4th of July 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Trinity Biotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trinity Biotech Backtesting, Trinity Biotech Valuation, Trinity Biotech Correlation, Trinity Biotech Hype Analysis, Trinity Biotech Volatility, Trinity Biotech History and analyze Trinity Biotech Performance. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Trinity Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.